CITRAPHOS

Citraphos tablet contains Ferric citrate as its active ingredient. This medication is utilized to address iron deficiency anemia and hyperphosphatemia, which refers to elevated phosphate levels in the body. It acts as a phosphate binder, specifically prescribed to control hyperphosphatemia in chronic kidney patients who are undergoing dialysis. Additionally, it serves as an iron supplement, supplying the elemental iron required for the production of red blood cells. Iron is crucial for the synthesis of hemoglobin, a protein found in red blood cells that transports oxygen throughout the body, and it is also vital for overall energy production and metabolism. This medication is frequently prescribed when oral iron supplements are either inadequate or poorly tolerated.

It is important to inform your healthcare provider about any existing medical conditions, including gastrointestinal disorders, liver disease, kidney disease, or other health issues. These conditions may necessitate special precautions or modifications in the use of Citraphos tablets. Specific gastrointestinal disorders, such as ulcerative colitis, Crohn’s disease, or other conditions affecting iron absorption, may require additional caution when using Citraphos tablets. The underlying condition should be effectively managed and optimized prior to considering iron supplementation. If you have a known allergy or hypersensitivity to Citraphos tablet or any of its components, you should refrain from using it. This medication is contraindicated in individuals with iron overload conditions, such as hemochromatosis, hemosiderosis, or other disorders that lead to excessive iron accumulation in the body.